Literature DB >> 6721556

Idiopathic thrombocytopenia, initial illness and long term follow up.

R W Walker, W Walker.   

Abstract

One hundred and eighty one children with thrombocytopenia for which no cause could be found have been studied. One patient died with severe bleeding possibly from disseminated intravascular coagulation and one developed cerebral haemorrhage, both within two weeks of onset. Ninety one per cent of the 135 with acute disease but only 36% of those with chronic disease remitted spontaneously. Twenty per cent of spontaneous remission occurred more than one year after onset. Six patients have run an intermittent course for 10 to 20 years. Four patients have had symptomless thrombocytopenia for between 10 and 30 years. Of 32 children treated by splenectomy 24 maintained normal platelet values thereafter. One boy died from pneumococcal septicaemia two years after splenectomy but he had not received prophylactic penicillin. One hundred and fifty eight patients were followed up 3 to 37 years (mean 16.4 years) after onset. None who recovered spontaneously or after splenectomy had had further bleeding problems. No patient nor immediate relative had developed other autoimmune disease. We consider that a short course of corticosteroids immediately after diagnosis is justified in all cases even though we cannot produce proof that it influences the course of the disease. We do not accept any place for long term immunosuppressant treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6721556      PMCID: PMC1628655          DOI: 10.1136/adc.59.4.316

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  30 in total

1.  Idiopathic thrombocytopenic purpura in childhood.

Authors:  J H WALKER; W WALKER
Journal:  Arch Dis Child       Date:  1961-12       Impact factor: 3.791

2.  Prognosis in idiopathic thrombocytopenic purpura of childhood.

Authors:  G M KOMROWER; G H WATSON
Journal:  Arch Dis Child       Date:  1954-12       Impact factor: 3.791

3.  Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.

Authors:  N R Shulman; V J Marder; R S Weinrach
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

Review 4.  Management of childhood idiopathic thrombocytopenic purpura.

Authors:  J S Lilleyman
Journal:  Br J Haematol       Date:  1983-05       Impact factor: 6.998

5.  Platelet antibody levels do not correlate with response to therapy in idiopathic thrombocytopenic purpura.

Authors:  M Kernoff; E Malan
Journal:  Br J Haematol       Date:  1983-04       Impact factor: 6.998

6.  Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura.

Authors:  W J HARRINGTON; V MINNICH; J W HOLLINGSWORTH; C V MOORE
Journal:  J Lab Clin Med       Date:  1951-07

7.  The thrombocytopenic effect of sustained high-dosage prednisone therapy in thrombocytopenic purpura.

Authors:  P COHEN; F H GARDNER
Journal:  N Engl J Med       Date:  1961-09-28       Impact factor: 91.245

8.  A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura.

Authors:  J G Kelton; P J Powers; C J Carter
Journal:  Blood       Date:  1982-10       Impact factor: 22.113

9.  Chronic idiopathic thrombocytopenia treated with immunoglobulin.

Authors:  P G Mori; G Mancuso; D del Principe; M Duse; R Miniero; R Tovo; M Bardare; V Carnelli; D de Mattia
Journal:  Arch Dis Child       Date:  1983-11       Impact factor: 3.791

10.  Danazol for the treatment of idiopathic thrombocytopenic purpura.

Authors:  Y S Ahn; W J Harrington; S R Simon; R Mylvaganam; L M Pall; A G So
Journal:  N Engl J Med       Date:  1983-06-09       Impact factor: 91.245

View more
  14 in total

1.  Serum immunoglobulin levels at onset: association with the prognosis of childhood idiopathic thrombocytopenic purpura.

Authors:  Masaru Kubota; Ikuya Usami; Ken-ichiro Kobayashi; Tsutomu Tsutsui; Kousaku Matsubara
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

2.  Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.

Authors:  O B Eden; J S Lilleyman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

3.  Splenunculectomy in thrombocytopenic purpura.

Authors:  M M Reid; P W Saunders; J D Fenwick; W Walker
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

4.  Chronic idiopathic thrombocytopenic purpura: primum non nocere.

Authors:  J Chessells
Journal:  Arch Dis Child       Date:  1989-09       Impact factor: 3.791

5.  Chronic idiopathic thrombocytopenic purpura: incidence, treatment, and outcome.

Authors:  M M Reid
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

6.  Idiopathic thrombocytopenic purpura: predictors of chronic disease.

Authors:  L G Robb; K Tiedeman
Journal:  Arch Dis Child       Date:  1990-05       Impact factor: 3.791

Review 7.  Overview of ITP treatment modalities in children.

Authors:  G R Buchanan
Journal:  Blut       Date:  1989-07

8.  Late spontaneous recovery of chronic thrombocytopenia.

Authors:  R C Tait; D I Evans
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

Review 9.  The nontreatment of childhood idiopathic thrombocytopenic purpura.

Authors:  G R Buchanan
Journal:  Eur J Pediatr       Date:  1987-03       Impact factor: 3.183

Review 10.  Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology.

Authors:  J S Lilleyman
Journal:  Arch Dis Child       Date:  1994-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.